Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Archives of Internal Medicine|March 25, 1999
Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: forecasting the incremental benefits of preventing coronary and cerebrovascular eventsS A Grover, L Coupal, S Paquet, et al.Journal of Cardiopulmonary Rehabilitation|June 22, 2000
The cost-effectiveness of exercise training for the primary and secondary prevention of cardiovascular diseaseI Lowensteyn, L Coupal, H Zowall, et al.Circulation|August 16, 2000
Cost-effectiveness of treating hyperlipidemia in the presence of diabetes : who should be treated?S A Grover, L Coupal, H Zowall, et al.Archives of Internal Medicine|April 1, 1998
Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary preventionS A Grover, S Paquet, C Levinton, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 15, 1990
HIV antibody screening among immigrants: a cost-benefit analysisH Zowall, R D Fraser, N Gilmore, et al.JAMA|April 5, 1995
The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-CV H Hamilton, F E Racicot, H Zowall, et al.BJOG : an International Journal of Obstetrics and Gynaecology|March 13, 2008
Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroidsH Zowall, J A Cairns, C Brewer, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 15, 1992
Economic impact of HIV infection and coronary heart disease in immigrants to CanadaH Zowall, L Coupal, R D Fraser, et al.Diabetes Care|February 24, 2001
How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?S A Grover, L Coupal, H Zowall, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 14, 2000
The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer ModelS A Grover, L Coupal, H Zowall, et al.Pageof 2